Organization
Pusan National University School of Medicine
3 abstracts
Abstract
ctDNA as a biomarker in phase II study of tepotinib in advanced solid cancers with MET exon 14 skipping mutation or amplification (KCSG AL19-17).Org: Chungbuk Univeristy Hospital, Chungbuk University College of Medicine, Inje University College of Medicine, Pusan National University School of Medicine, Chonnam National University Hwasun Hospital,
Abstract
Phase II study about efficacy and safety of the continuous intravenous infusion of ketamine as adjuvant to opioids in terminally ill cancer patients with refractory cancer pain.Org: Hanyang University Seoul Hospital, Hanyang University College of Medicine, Hanyang University College of Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Department of Family Medicine, Pusan National University Yangsan Hospital,
Abstract
Clinical outcomes of extramammary Paget’s disease in Korea: A multicenter, retrospective study.Org: Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul, South Korea, Asan Medical Center, Seoul National University Hospital, Samsung Medical Center, Seoul St. Mary's Hospital,